Best original research presented at the 27th European Congress on Gynaecological Oncology: best of ESGO 2026.

Abstract

The Best of the European Society of Gynaecological Oncology 2026 review highlights a selection of the best original research presented at the 27th Congress of the European Society of Gynaecological Oncology, held February 26 to 28, 2026, in Copenhagen, Denmark. Of the 1585 abstracts submitted, the ESGO Scientific Programme Committee chairs and authors from the European Network of Young Gynae Oncologists selected 31 high-impact studies for inclusion in this compilation. This included 10 Best Oral Sessions abstracts, 10 Mini Oral Sessions abstracts, 9 Young Investigator Session abstracts, and 2 Best 3-Minute Presentations abstracts. Key research themes this year included implementation of updated European Society of Gynaecological Oncology ovarian and endometrial cancer guidelines, refinement of surgical strategies in advanced and recurrent ovarian cancer, advances in immunotherapy and non-chemotherapy combinations, biomarker testing and personalized surgery as part of precision oncology, human epidermal growth factor receptor 2-directed therapies and antibody-drug conjugates, management of rare tumors, and innovations in prevention, diagnosis, and cervical cancer care. Through this initiative, European Society of Gynaecological Oncology and European Network of Young Gynae Oncologists aim to showcase the most impactful developments in gynaecologic oncology research and to facilitate their dissemination to clinicians, researchers, patients, advocacy groups, and allied professionals across Europe and internationally.